Kimberley Holt

P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study

Rayid Abdulqawi, Rachel Dockry, Kimberley Holt et al. · The Lancet · 2014 · 483 citations

Medicine, Pharmacology, Pharmacotherapy +10

Randomised feasibility study of physiotherapy for patients with functional motor symptoms

Glenn Nielsen, Marta Buszewicz, Fiona Stevenson et al. · Journal of Neurology Neurosurgery & Psychiatry · 2016 · 244 citations · Full text

Medicine, Neurology, Rehabilitation Medicine +15

Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: A double-blind randomized controlled trial

Saifudin Khalid, Robert Murdoch, Amy Newlands et al. · Journal of Allergy and Clinical Immunology · 2014 · 187 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough

Maria G. Belvisi, Mark A. Birrell, Michael A. Wortley et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 156 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Objective cough frequency in Idiopathic Pulmonary Fibrosis

Angela Key, Kimberley Holt, Andrew Hamilton et al. · Cough · 2010 · 155 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17